Alembic Pharma gets USFDA nod for Fingolimod capsules; targets $145 million market

Alembic Pharmaceuticals gets USFDA nod for generic Fingolimod capsules, adding to recent Dapagliflozin and Methotrexate approvals, stock down Friday but up over the past month

Leave a Reply

Your email address will not be published. Required fields are marked *